WO2007013894A3 - Phospholipid ether analogs for detecting and treating cancer - Google Patents
Phospholipid ether analogs for detecting and treating cancer Download PDFInfo
- Publication number
- WO2007013894A3 WO2007013894A3 PCT/US2005/047657 US2005047657W WO2007013894A3 WO 2007013894 A3 WO2007013894 A3 WO 2007013894A3 US 2005047657 W US2005047657 W US 2005047657W WO 2007013894 A3 WO2007013894 A3 WO 2007013894A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer
- detecting
- phospholipid ether
- ether analogs
- treating cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05858499A EP1833514A2 (en) | 2004-12-20 | 2005-12-20 | Phospholipid ether analogs for detecting and treating cancer |
MX2007007497A MX2007007497A (en) | 2004-12-20 | 2005-12-20 | Phospholipid ether analogs for detecting and treating cancer. |
JP2007548624A JP2008545614A (en) | 2004-12-20 | 2005-12-20 | Phospholipid ether analogs for cancer detection and therapy |
CA002591907A CA2591907A1 (en) | 2004-12-20 | 2005-12-20 | Phospholipid ether analogs for detecting and treating cancer |
US11/382,645 US7632644B2 (en) | 2004-03-02 | 2006-05-10 | Imaging and selective retention of phospholipid ether analogs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59319004P | 2004-12-20 | 2004-12-20 | |
US60/593,190 | 2004-12-20 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/006681 Continuation-In-Part WO2005084716A2 (en) | 2004-03-02 | 2005-03-02 | Phospholipid analogs for diagnosis and treatment of cancer |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/024259 Continuation-In-Part WO2006014589A2 (en) | 2004-03-02 | 2005-07-08 | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
US11/382,645 Continuation-In-Part US7632644B2 (en) | 2004-03-02 | 2006-05-10 | Imaging and selective retention of phospholipid ether analogs |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007013894A2 WO2007013894A2 (en) | 2007-02-01 |
WO2007013894A9 WO2007013894A9 (en) | 2007-03-29 |
WO2007013894A3 true WO2007013894A3 (en) | 2007-04-19 |
Family
ID=37564093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/047657 WO2007013894A2 (en) | 2004-03-02 | 2005-12-20 | Phospholipid ether analogs for detecting and treating cancer |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1833514A2 (en) |
JP (1) | JP2008545614A (en) |
KR (1) | KR20080005178A (en) |
CA (1) | CA2591907A1 (en) |
MX (1) | MX2007007497A (en) |
WO (1) | WO2007013894A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8540968B2 (en) | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
EP2044960B1 (en) * | 2004-03-02 | 2013-11-20 | Cellectar, Inc. | Phospholipid analogue for the in vivo diagnosis of cancers |
AU2005269861A1 (en) * | 2004-07-08 | 2006-02-09 | Cellectar, Llc | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
WO2010132428A1 (en) * | 2009-05-11 | 2010-11-18 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
ES2799411T3 (en) | 2009-06-12 | 2020-12-17 | Cellectar Inc | Alkylphospholipid compounds for cancer treatment and cancer stem cell imaging and detection |
US20110064661A1 (en) * | 2009-09-11 | 2011-03-17 | Pinchuk Anatoly | Non-radioactive phospholipid compounds, compositions, and methods of use |
PT3229810T (en) * | 2014-11-17 | 2020-08-27 | Cellectar Biosciences Inc | Phospholipid ether analogs as cancer-targeting drug vehicles |
JP6666757B2 (en) * | 2016-03-10 | 2020-03-18 | 日本メジフィジックス株式会社 | Method for quantifying polyoxyethylene nonionic surfactant and method for producing radiopharmaceutical preparation |
NZ749272A (en) * | 2016-06-14 | 2023-01-27 | Cellectar Biosciences Inc | Phospholipid ether analogs for the identification and isolation of circulating tumor cells |
EP3484513B1 (en) * | 2016-07-18 | 2023-06-07 | Wisconsin Alumni Research Foundation | Radiohalogenated agents for combined cancer therapy |
US11633506B2 (en) | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
CA3031776C (en) * | 2016-07-25 | 2024-02-20 | Wisconsin Alumni Research Foundation | Targeted radiotherapy chelates for in situ immune modulated cancer vaccination |
KR20200088374A (en) * | 2017-11-10 | 2020-07-22 | 위스콘신 얼럼나이 리서어치 화운데이션 | Methods of using targeted radiotherapy (TRT) to induce an anti-tumor immune response to immunotherapy |
CA3096677A1 (en) * | 2018-04-10 | 2019-10-17 | Cellectar Biosciences, Inc. | Fractionated dosing of a phospholipid ether analog for the treatment of cancer |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998024480A1 (en) * | 1996-12-04 | 1998-06-11 | The Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
US5795561A (en) * | 1987-10-23 | 1998-08-18 | The Board Of Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogues |
WO2005084716A2 (en) * | 2004-03-02 | 2005-09-15 | Cellectar, Llc | Phospholipid analogs for diagnosis and treatment of cancer |
WO2006014589A2 (en) * | 2004-07-08 | 2006-02-09 | Cellectar, Llc | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
-
2005
- 2005-12-20 EP EP05858499A patent/EP1833514A2/en not_active Withdrawn
- 2005-12-20 KR KR1020077016834A patent/KR20080005178A/en not_active Application Discontinuation
- 2005-12-20 WO PCT/US2005/047657 patent/WO2007013894A2/en active Application Filing
- 2005-12-20 MX MX2007007497A patent/MX2007007497A/en not_active Application Discontinuation
- 2005-12-20 JP JP2007548624A patent/JP2008545614A/en active Pending
- 2005-12-20 CA CA002591907A patent/CA2591907A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795561A (en) * | 1987-10-23 | 1998-08-18 | The Board Of Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogues |
WO1998024480A1 (en) * | 1996-12-04 | 1998-06-11 | The Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
WO2005084716A2 (en) * | 2004-03-02 | 2005-09-15 | Cellectar, Llc | Phospholipid analogs for diagnosis and treatment of cancer |
WO2006014589A2 (en) * | 2004-07-08 | 2006-02-09 | Cellectar, Llc | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
Non-Patent Citations (1)
Title |
---|
WEICHERT J P ET AL: "Initial Clinical Imaging Results with NM404 in Non-Small Cell Lung Cancer", MOLECULAR IMAGING, MIT PRESS,, US, vol. 3, no. 3, July 2004 (2004-07-01), pages 269 - 270, XP002365141, ISSN: 1535-3508 * |
Also Published As
Publication number | Publication date |
---|---|
EP1833514A2 (en) | 2007-09-19 |
CA2591907A1 (en) | 2007-02-01 |
KR20080005178A (en) | 2008-01-10 |
JP2008545614A (en) | 2008-12-18 |
MX2007007497A (en) | 2008-01-11 |
WO2007013894A9 (en) | 2007-03-29 |
WO2007013894A2 (en) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007013894A3 (en) | Phospholipid ether analogs for detecting and treating cancer | |
MX2009012906A (en) | Monoclonal antibodies against claudin-18 for treatment of cancer. | |
Hu et al. | miR-124 inhibits growth and invasion of gastric cancer by targeting ROCK1 | |
Zebary et al. | KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma | |
WO2005084716A3 (en) | Phospholipid analogs for diagnosis and treatment of cancer | |
PH12019501029A1 (en) | Fgfr4 inhibitor, preparation method therefor and pharmaceutical use therefor | |
MX346973B (en) | Tumor specific antibodies and uses therefor. | |
WO2006052823A3 (en) | Biomarkers for prostate cancer metastasis | |
WO2008104804A3 (en) | Proteins | |
MY141605A (en) | Method of treating certain cancers using an estrogen agonist/antagonist | |
WO2004045521A3 (en) | Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr | |
NZ748500A (en) | 1-tetrahydropyranylcarbonyl-2,3-dihydro-1h-indole compounds for treating cancer | |
WO2009038754A3 (en) | Gene expression signatures in enriched tumor cell samples | |
WO2006012646A3 (en) | Amacr cancer markers | |
MX2011012584A (en) | BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE. | |
HK1108284A1 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
IL266563B (en) | Heterocyclic compounds useful as pdk1 inhibitors | |
MY183404A (en) | Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors | |
HK1131165A1 (en) | Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors | |
TR201802090T4 (en) | Monoclonal anti-GT468 antibodies for the treatment of cancer. | |
MX2009013765A (en) | Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof. | |
MX2009009816A (en) | Monoclonal antibodies for treatment of cancer. | |
MX2022013783A (en) | Copper-containing theragnostic compounds and methods of use. | |
WO2008104805A3 (en) | Proteins | |
EP1654377A4 (en) | Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 11382645 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 11382645 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2591907 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/007497 Country of ref document: MX Ref document number: 2007548624 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005858499 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077016834 Country of ref document: KR |